XML 41 R28.htm IDEA: XBRL DOCUMENT v3.21.2

Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Disaggregation of Revenue [Line Items]
Net sales	$ 4,160	$ 3,737	$ 12,407	$ 10,089
United States
Disaggregation of Revenue [Line Items]
Net sales	3,019	2,748	8,903	7,357
International
Disaggregation of Revenue [Line Items]
Net sales	1,141	989	3,504	2,732
Orthopaedics
Disaggregation of Revenue [Line Items]
Net sales	1,529	1,317	4,641	3,433
Orthopaedics | United States
Disaggregation of Revenue [Line Items]
Net sales	1,064	937	3,222	2,412
Orthopaedics | International
Disaggregation of Revenue [Line Items]
Net sales	465	380	1,419	1,021
Orthopaedics | Knees
Disaggregation of Revenue [Line Items]
Net sales	439	435	1,325	1,108
Orthopaedics | Knees | United States
Disaggregation of Revenue [Line Items]
Net sales	321	332	964	833
Orthopaedics | Knees | International
Disaggregation of Revenue [Line Items]
Net sales	118	103	361	275
Orthopaedics | Hips
Disaggregation of Revenue [Line Items]
Net sales	328	334	990	866
Orthopaedics | Hips | United States
Disaggregation of Revenue [Line Items]
Net sales	199	223	606	564
Orthopaedics | Hips | International
Disaggregation of Revenue [Line Items]
Net sales	129	111	384	302
Orthopaedics | Trauma and Extremities
Disaggregation of Revenue [Line Items]
Net sales	639	430	1,953	1,152
Orthopaedics | Trauma and Extremities | United States
Disaggregation of Revenue [Line Items]
Net sales	447	285	1,362	753
Orthopaedics | Trauma and Extremities | International
Disaggregation of Revenue [Line Items]
Net sales	192	145	591	399
Orthopaedics | Other
Disaggregation of Revenue [Line Items]
Net sales	123	118	373	307
Orthopaedics | Other | United States
Disaggregation of Revenue [Line Items]
Net sales	97	97	290	262
Orthopaedics | Other | International
Disaggregation of Revenue [Line Items]
Net sales	26	21	83	45
MedSurg
Disaggregation of Revenue [Line Items]
Net sales	1,755	1,600	5,124	4,546
MedSurg | United States
Disaggregation of Revenue [Line Items]
Net sales	1,397	1,269	4,007	3,567
MedSurg | International
Disaggregation of Revenue [Line Items]
Net sales	358	331	1,117	979
MedSurg | Instruments
Disaggregation of Revenue [Line Items]
Net sales	525	467	1,511	1,308
MedSurg | Instruments | United States
Disaggregation of Revenue [Line Items]
Net sales	415	369	1,171	1,028
MedSurg | Instruments | International
Disaggregation of Revenue [Line Items]
Net sales	110	98	340	280
MedSurg | Endoscopy
Disaggregation of Revenue [Line Items]
Net sales	525	467	1,512	1,238
MedSurg | Endoscopy | United States
Disaggregation of Revenue [Line Items]
Net sales	418	380	1,179	997
MedSurg | Endoscopy | International
Disaggregation of Revenue [Line Items]
Net sales	107	87	333	241
MedSurg | Medical
Disaggregation of Revenue [Line Items]
Net sales	636	600	1,898	1,819
MedSurg | Medical | United States
Disaggregation of Revenue [Line Items]
Net sales	496	455	1,457	1,363
MedSurg | Medical | International
Disaggregation of Revenue [Line Items]
Net sales	140	145	441	456
MedSurg | Sustainability
Disaggregation of Revenue [Line Items]
Net sales	69	66	203	181
MedSurg | Sustainability | United States
Disaggregation of Revenue [Line Items]
Net sales	68	65	200	179
MedSurg | Sustainability | International
Disaggregation of Revenue [Line Items]
Net sales	1	1	3	2
Neurotechnology and Spine
Disaggregation of Revenue [Line Items]
Net sales	876	820	2,642	2,110
Neurotechnology and Spine | United States
Disaggregation of Revenue [Line Items]
Net sales	558	542	1,674	1,378
Neurotechnology and Spine | International
Disaggregation of Revenue [Line Items]
Net sales	318	278	968	732
Neurotechnology and Spine | Neurotechnology
Disaggregation of Revenue [Line Items]
Net sales	594	518	1,775	1,370
Neurotechnology and Spine | Neurotechnology | United States
Disaggregation of Revenue [Line Items]
Net sales	357	323	1,063	835
Neurotechnology and Spine | Neurotechnology | International
Disaggregation of Revenue [Line Items]
Net sales	237	195	712	535
Neurotechnology and Spine | Spine
Disaggregation of Revenue [Line Items]
Net sales	282	302	867	740
Neurotechnology and Spine | Spine | United States
Disaggregation of Revenue [Line Items]
Net sales	201	219	611	543
Neurotechnology and Spine | Spine | International
Disaggregation of Revenue [Line Items]
Net sales	$ 81	$ 83	$ 256	$ 197

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_KneesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_HipsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_MedsurgMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_InstrumentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_EndoscopyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_MedicalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_SustainabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=syk_NeurotechnologyAndSpineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_NeurotechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=syk_SpineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: